• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病预防干预措施的成本效益:一项系统文献综述

Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.

作者信息

Vijgen Sylvia M C, Hoogendoorn Mirjam, Baan Caroline A, de Wit G Ardine, Limburg Wien, Feenstra Talitha L

机构信息

Department for Prevention and Health Services Research, National Institute of Public Health and Environment (RIVM), Bilthoven, The Netherlands.

出版信息

Pharmacoeconomics. 2006;24(5):425-41. doi: 10.2165/00019053-200624050-00002.

DOI:10.2165/00019053-200624050-00002
PMID:16706569
Abstract

A systematic review of the literature was conducted to give an overview of economic evaluations of preventive interventions in type 2 diabetes mellitus. The interventions were sorted by type of preventive intervention (primary, secondary or tertiary) and by category (e.g. education, medication for hypertension). Several databases were searched for studies published between January 1990 and May 2004 on the three types of preventive intervention. For each study selected, inclusion of specific components from a standardised list of items, including quality, was recorded in a database. Summary tables were generated based on the database.A number of conclusions were drawn from this review. The most important was that strict blood pressure control was a more cost-effective intervention than less strict control, as shown by six studies reporting cost savings to very low costs per life-year gained. Primary and secondary prevention of type 2 diabetes were also highly cost effective, but these results were based on very few studies. Medications to reduce weight and hyperglycaemia together were cost effective compared with conventional interventions. Finally, the separate results regarding medications to reduce weight, hyperglycaemia and hypercholesterolaemia varied enormously, thus no conclusion could be drawn and further economic analysis is required.

摘要

对文献进行了系统综述,以概述2型糖尿病预防干预措施的经济学评价。干预措施按预防干预类型(一级、二级或三级)和类别(如教育、高血压用药)进行分类。检索了几个数据库,以查找1990年1月至2004年5月期间发表的关于这三种预防干预类型的研究。对于每项入选研究,将来自标准化项目列表(包括质量)的特定组成部分的纳入情况记录在一个数据库中。根据该数据库生成了汇总表。本次综述得出了一些结论。最重要的是,六项研究表明,严格控制血压比不太严格的控制更具成本效益,每获得一个生命年的成本节约至非常低的成本。2型糖尿病的一级和二级预防也具有很高的成本效益,但这些结果基于非常少的研究。与传统干预措施相比,联合使用减轻体重和高血糖的药物具有成本效益。最后,关于减轻体重、高血糖和高胆固醇血症药物的单独结果差异极大,因此无法得出结论,需要进一步进行经济学分析。

相似文献

1
Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.2型糖尿病预防干预措施的成本效益:一项系统文献综述
Pharmacoeconomics. 2006;24(5):425-41. doi: 10.2165/00019053-200624050-00002.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review.针对青少年糖尿病患者的教育和心理社会干预措施的效果:一项系统评价
Health Technol Assess. 2001;5(10):1-79. doi: 10.3310/hta5100.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.肥胖治疗的长期效果、经济后果及其对健康改善影响的系统评价
Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. doi: 10.3310/hta8210.
9
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
10
Interventions for preventing falls in Parkinson's disease.预防帕金森病跌倒的干预措施。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD011574. doi: 10.1002/14651858.CD011574.pub2.

引用本文的文献

1
Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis.通过护士主导的远程辅导提供糖尿病教育。成本效益分析。
PLoS One. 2016 Oct 11;11(10):e0163997. doi: 10.1371/journal.pone.0163997. eCollection 2016.
2
Cost effectiveness of type 2 diabetes screening: A systematic review.2型糖尿病筛查的成本效益:一项系统评价。
Med J Islam Repub Iran. 2016 Feb 13;30:326. eCollection 2016.
3
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.

本文引用的文献

1
A decision chart for assessing and improving the transferability of economic evaluation results between countries.一份用于评估和提高经济评估结果在不同国家之间可转移性的决策图表。
Pharmacoeconomics. 2004;22(13):857-76. doi: 10.2165/00019053-200422130-00004.
2
Application of economic analysis to diabetes and diabetes care.经济分析在糖尿病及糖尿病护理中的应用。
Ann Intern Med. 2004 Jun 1;140(11):972-7. doi: 10.7326/0003-4819-140-11-200406010-00039.
3
Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.2型糖尿病筛查:一项成本效益分析。
联合饮食与身体活动促进项目预防高危人群2型糖尿病的经济评估:社区预防服务工作组的系统评价
Ann Intern Med. 2015 Sep 15;163(6):452-60. doi: 10.7326/M15-0469.
4
Nurse-led telecoaching of people with type 2 diabetes in primary care: rationale, design and baseline data of a randomized controlled trial.初级保健中护士主导的2型糖尿病患者远程指导:一项随机对照试验的基本原理、设计和基线数据
BMC Fam Pract. 2014 Feb 4;15:24. doi: 10.1186/1471-2296-15-24.
5
Comparative effectiveness and child health.比较疗效和儿童健康。
Pharmacoeconomics. 2012 Aug 1;30(8):637-45. doi: 10.2165/11633830-000000000-00000.
6
Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention.目标性预防与普遍性预防。一种资源分配模型,用于确定心血管疾病预防的优先顺序。
Cost Eff Resour Alloc. 2011 Oct 6;9(1):14. doi: 10.1186/1478-7547-9-14.
7
Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.生活方式干预预防糖尿病和心血管疾病的经济评价。
Int J Environ Res Public Health. 2010 Aug;7(8):3150-95. doi: 10.3390/ijerph7083150. Epub 2010 Aug 9.
8
Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.预防和控制糖尿病的干预措施的成本效益:系统评价。
Diabetes Care. 2010 Aug;33(8):1872-94. doi: 10.2337/dc10-0843.
9
A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment.糖尿病治疗的长期成本效益模型中使用的方法综述。
Pharmacoeconomics. 2010;28(4):255-77. doi: 10.2165/11531590-000000000-00000.
10
Exercise therapy in type 2 diabetes.运动疗法在 2 型糖尿病中的应用。
Acta Diabetol. 2009 Dec;46(4):263-78. doi: 10.1007/s00592-009-0129-0. Epub 2009 May 29.
Ann Intern Med. 2004 May 4;140(9):689-99. doi: 10.7326/0003-4819-140-9-200405040-00008.
4
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.全球糖尿病患病率:2000年的估计数及2030年的预测数。
Diabetes Care. 2004 May;27(5):1047-53. doi: 10.2337/diacare.27.5.1047.
5
Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.从德国法定医疗保健角度看吡格列酮联合疗法治疗2型糖尿病的成本效益
Pharmacoeconomics. 2004;22(5):321-41. doi: 10.2165/00019053-200422050-00006.
6
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.糖耐量受损患者强化生活方式改变或使用二甲双胍:模拟澳大利亚、法国、德国、瑞士和英国糖尿病预防项目的长期健康经济影响。
Clin Ther. 2004 Feb;26(2):304-21. doi: 10.1016/s0149-2918(04)90029-x.
7
Screening for type 2 diabetes.2型糖尿病筛查
Diabetes Care. 2004 Jan;27 Suppl 1:S11-4. doi: 10.2337/diacare.27.2007.s11.
8
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.
Clin Ther. 2003 Jul;25(7):2102-19. doi: 10.1016/s0149-2918(03)80208-4.
9
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.生活方式干预或二甲双胍用于2型糖尿病一级预防的试验内成本效益
Diabetes Care. 2003 Sep;26(9):2518-23. doi: 10.2337/diacare.26.9.2518.
10
The economics of screening and treatment in type 2 diabetes mellitus.2型糖尿病的筛查与治疗经济学
Pharmacoeconomics. 2003;21(8):543-64. doi: 10.2165/00019053-200321080-00002.